Peptide inhibitors of mammalian ribonucleotide reductase

Advances in Enzyme Regulation

Volumn 45, Issue 1, 2005, Pages 112-125

  Cooperman, Barry S ^a   Gao, Ying ^a   Tan, Chiheng ^a   Kashlan, Ossama B ^a   Kaur, Jaskiran ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA; RHODOCOCCUS RHODOCHROUS;

EID: 28444453986     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2005.02.012     Document Type: Article

References (47)

1. A.M. Bonvin, J.A. Rullmann, R.M. Lamerichs, R. Boelens, and R. Kaptein "Ensemble" iterative relaxation matrix approach: a new NMR refinement protocol applied to the solution structure of crambin Proteins: Struct Funct Genet 15 1993 385 400
2. C.R. Brandt, B. Spencer, P. Imesch, M. Garneau, and R. Deziel Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease Antimicrob Agents Chemother 40 1996 1078 1084
3. D.S. Byun, K.S. Chae, B.K. Ryu, M.G. Lee, and S.G. Chi Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma Int J Cancer 98 2002 718 723
4. A. Chabes, and L. Thelander Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks J Biol Chem 275 2000 17747 17753
5. L.L. Chang, J. Hannah, W.T. Ashton, G.H. Rasmusson, T.J. Ikeler, G.F. Patel, V. Garsky, C. Uncapher, G. Yamanaka, and W.L. McClements Substituted penta- and hexapeptides as potent inhibitors of Herpes simplex virus type 2 ribonucleotide reductase Bioorg Med Chem Lett 2 1992 1207 1212
6. E.A. Cohen, P. Gaudreau, P. Brazeau, and Y. Langelier Specific inhibition of herpes virus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2 Nature 321 1986 441 443
7. J.G. Cory Ribonucleotide reductase as a chemotherapeutic target Adv Enzyme Regul 27 1988 437
8. G. Cosentino, P. Lavallee, S. Rakhit, R. Plante, Y. Gaudette, C. Lawetz, P.W. Whitehead, J.S. Duceppe, C. Lepine-Frenette, and N. Dansereau Specific inhibition of ribonucleotide reductases by peptides corresponding to the C-terminal of their second subunit Biochem Cell Biol 69 1991 79 83
9. F. Delaglio, S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, and A. Bax NMR Pipe: a multidimensional spectral processing system based on UNIX pipes J Biomol NMR 6 1995 277 293
10. J. Duan, M. Liuzzi, W. Paris, M. Lambert, C. Lawetz, N. Moss, J. Jaramillo, J. Gauthier, R. Deziel, and M.G. Cordingley Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo Antimicrob Agents Chemother 42 1998 1629 1635
11. B.M. Dutia, M.C. Frame, J.H. Subak-Sharpe, W.N. Clark, and H.S. Marsden Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides Nature 321 1986 439 441
12. H. Eklund, U. Uhlin, M. Farnegardh, D.T. Logan, and P. Nordlund Structure and function of the radical enzyme ribonucleotide reductase Prog Biophys Mol Biol 77 2001 177
13. M. Eriksson, U. Uhlin, S. Ramaswamy, M. Ekberg, K. Regnstrom, B.M. Sjoberg, and H. Eklund Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding Structure 5 1997 1077 1092
14. A. Fisher, F.D. Yang, H. Rubin, and B.S. Cooperman R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase J Med Chem 36 1993 3859 3862
15. A. Fisher, P.B. Laub, and B.S. Cooperman NMR structure of an inhibitory R2 C-terminal peptide bound to mouse ribonucleotide reductase R1 subunit Nat Struct Biol 2 1995 951 955
16. Y. Gao, S. Liehr, and B.S. Cooperman Affinity-driven selection of tripeptide inhibitors of ribonucleotide reductase Bioorg Med Chem Lett 12 2002 513 515
17. Y. Gao, O.B. Kashlan, J. Kaur, C. Tan, and B.S. Cooperman Mechanisms of action of peptide inhibitors of mammalian ribonucleotide reductase targeting quaternary structure Biopolymers (Peptide Science) 80 2005 9 17
18. P. Gaudreau, J. Michaud, E.A. Cohen, Y. Langelier, and P. Brazeau Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase J Biol Chem 262 1987 12413 12416
19. P. Gaudreau, H. Paradis, Y. Langelier, and P. Brazeau Synthesis and inhibitory potency of peptides corresponding to the subunit 2 C-terminal region of herpes virus ribonucleotide reductases J Med Chem 33 1990 723 730
20. P. Gaudreau, P. Brazeau, M. Richer, J. Cormier, D. Langlois, and Y. Langelier Structure-function studies of peptides inhibiting the ribonucleotide reductase activity of herpes simplex virus type I J Med Chem 35 1992 346 350
21. T.F. Havel An evaluation of computational strategies for use in the determination of protein structure from distance constraints obtained by nuclear magnetic resonance Prog Biophys Mol Biol 56 1991 43 78
22. O.B. Kashlan, and B.S. Cooperman A comprehensive model for the allosteric regulation of class Ia ribonucleotide reductases Biochemistry 42 2003 1696 1706
23. O.B. Kashlan, C.P. Scott, J.D. Lear, and B.S. Cooperman A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit Biochemistry 41 2002 462 474
24. S. Liehr, J. Barbosa, A.B. Smith 3rd, and B.S. Cooperman Synthesis and biological activity of cyclic peptide inhibitors of ribonucleotide reductase Org Lett 1 1999 1201 1204
25. M. Liuzzi, R. Deziel, N. Moss, P. Beaulieu, A.M. Bonneau, C. Bousquet, J.G. Chafouleas, M. Garneau, J. Jaramillo, and R.L. Krogsrud A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo Nature 372 1994 695 698
26. M. Llinas-Brunet, N. Moss, E. Scouten, M. Liuzzi, and R. Deziel Peptidomimetic inhibitors of Herpes virus ribonucleotide reductase. Correlation between Herpes simplex and Varicella zoster virus Bioorg Med Chem Lett 6 1996 2881 2886
27. D.S. Martin, J.R. Bertino, and J.A. Koutcher ATP depletion+pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach Cancer Res 60 2000 6776 6783
28. D.S. Martin, D. Spriggs, and J.A. Koutcher A concomitant ATP-depleting strategy markedly enhances anticancer agent activity Apoptosis 6 2001 125 131
29. N. Moss, R. Deziel, J. Adams, N. Aubry, M. Bailey, M. Baillet, P. Beaulieu, J. DiMaio, J.S. Duceppe, and J.M. Ferland Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives J Med Chem 36 1993 3005 3009
30. N. Moss, R. Deziel, J.M. Ferland, S. Goulet, P.J. Jones, S.F. Leonard, T.P. Pitner, and R. Plante Herpes simplex virus ribonucleotide reductase subunit association inhibitors: the effect and conformation of beta-alkylated aspartic acid derivatives Bioorg Med Chem 2 1994 959 970
31. N. Moss, P. Beaulieu, J.S. Duceppe, J.M. Ferland, J. Gauthier, E. Ghiro, S. Goulet, L. Grenier, M. Llinas-Brunet, and R. Plante Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents J Med Chem 38 1995 3617 3623
32. N. Moss, P. Beaulieu, J.S. Duceppe, J.M. Ferland, M. Garneau, J. Gauthier, E. Ghiro, S. Goulet, I. Guse, J. Jaramillo, M. Llinas-Brunet, E. Malenfant, R. Plante, M. Poirier, F. Soucy, D. Wernic, C. Yoakim, and R. Deziel Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity J Med Chem 39 1996 4173 4180
33. G. Nocentini Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy Crit Rev Oncol Hematol 22 1996 89 126
34. M. Pellegrini, S. Liehr, A.L. Fisher, P.B. Laub, B.S. Cooperman, and D.F. Mierke Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase Biochemistry 39 2000 12210 12215
35. B.A. Pender, X. Wu, P.H. Axelsen, and B.S. Cooperman Toward a rational design of peptide inhibitors of ribonucleotide reductase: structure-function and modeling studies J Med Chem 44 2001 36 46
36. M.J. Robins Mechanism-based inhibition of ribonucleotide reductases: new mechanistic considerations and promising biological applications Nucleosides Nucleotides 18 1999 779
37. J.B. Rothbard, S. Garlington, Q. Lin, T. Kirschberg, E. Kreider, P.L. McGrane, P.A. Wender, and P.A. Khavari Conjugation of arginine oligomers to cyclosporin. A facilitates topical delivery and inhibition of inflammation Nat Med 6 2000 1253 1257
38. C.P. Scott, O.B. Kashlan, J.D. Lear, and B.S. Cooperman A quantitative model for allosteric control of purine reduction by murine ribonucleotide reductase Biochemistry 40 2001 1651 1661
39. J. Stubbe, and W.A. van der Donk Ribonucleotide reductases: radical enzymes with suicidal tendencies Chem Biol 2 1995 793 801
40. T. Szekeres, M. Fritzer-Szekeres, and H.L. Elford The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy Crit Rev Clin Lab Sci 34 1997 503 528
41. C. Tan, Y. Gao, J. Kaur, and B.S. Cooperman More potent linear peptide inhibitors of mammalian ribonucleotide reductase Bioorg Med Chem Lett 14 2004 5301 5304
42. U. Uhlin, and H. Eklund Structure of ribonucleotide reductase protein R1 Nature 370 1994 533 539
43. C.J. van Moorsel, A.M. Bergman, G. Veerman, D.A. Voorn, V.W. Ruiz van Haperen, J.R. Kroep, H.M. Pinedo, and G.J. Peters Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines Biochim Biophys Acta 1474 2000 5 12
44. G. Weber Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture Cancer Res 43 1983 3466
45. L. Xue, B. Zhou, X. Liu, W. Qiu, Z. Jin, and Y. Yen Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits Cancer Res 63 2003 980 986
46. F.D. Yang, R.A. Spanevello, I. Celiker, R. Hirschmann, H. Rubin, and B.S. Cooperman The carboxyl terminus heptapeptide of the R2 subunit of mammalian ribonucleotide reductase inhibits enzyme activity and can be used to purify the R1 subunit FEBS Lett 272 1990 61 64
47. F. Yang, S.C. Curran, L.S. Li, D. Avarbock, J.D. Graf, M.M. Chua, G. Lu, J. Salem, and H. Rubin Characterization of two genes encoding the Mycobacterium tuberculosis ribonucleotide reductase small subunit J Bacteriol 179 1997 6408 6415